180-Day Exclusivity in Generic Drug Market Entry: How Patent Law Shapes Drug Prices
The 180-day exclusivity rule under the Hatch-Waxman Act was meant to speed up generic drug entry, but delays by first applicants often block competition for years-keeping prices high and patients waiting.